• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用于删失肿瘤生长延迟数据的中位失败时间差异的置信区间。

Confidence intervals for the difference of median failure times applied to censored tumor growth delay data.

作者信息

Wu Jianrong

机构信息

Department of Biostatistics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.

出版信息

Stat Biopharm Res. 2011;3(3):488-496. doi: 10.1198/sbr.2011.10020. Epub 2012 Jan 24.

DOI:10.1198/sbr.2011.10020
PMID:28966720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5621763/
Abstract

In tumor xenograft experiments, tumor response to the anti-cancer agents is often assessed by tumor growth delay, the difference in median tumor quadrupling times between treatment and control. Tumor quadrupling time is often subjected to right censoring because death of the experimental mice or limitations of the follow-up period. In the literature, tumor growth delay is simply reported without a standard error or confidence interval being given, which ignores the noise in the experimental data. Here, we present seven confidence intervals for the difference of medians in a general right-censored failure time framework. Simulation studies are conducted to compare the coverage probability of these intervals for small samples. The proposed intervals are applied to tumor growth delay data from an actual tumor xenograft experiment.

摘要

在肿瘤异种移植实验中,通常通过肿瘤生长延迟来评估肿瘤对抗癌药物的反应,即治疗组和对照组之间肿瘤体积增大四倍所需的中位时间之差。由于实验小鼠死亡或随访期有限,肿瘤体积增大四倍所需的时间常常受到右删失的影响。在文献中,仅报告了肿瘤生长延迟情况,未给出标准误差或置信区间,这忽略了实验数据中的噪声。在此,我们在一般的右删失失效时间框架下,给出了中位数差异的七个置信区间。进行了模拟研究以比较这些区间在小样本情况下的覆盖概率。所提出的区间应用于实际肿瘤异种移植实验的肿瘤生长延迟数据。

相似文献

1
Confidence intervals for the difference of median failure times applied to censored tumor growth delay data.应用于删失肿瘤生长延迟数据的中位失败时间差异的置信区间。
Stat Biopharm Res. 2011;3(3):488-496. doi: 10.1198/sbr.2011.10020. Epub 2012 Jan 24.
2
Methods for analysis of censored tumor growth delay data.截尾肿瘤生长延迟数据的分析方法。
Radiat Res. 1990 May;122(2):172-80.
3
Conformal predictive intervals in survival analysis: a resampling approach.生存分析中的共形预测区间:一种重采样方法。
Biometrics. 2025 Apr 2;81(2). doi: 10.1093/biomtc/ujaf063.
4
Finite sample pointwise confidence intervals for a survival distribution with right-censored data.具有右删失数据的生存分布的有限样本逐点置信区间。
Stat Med. 2016 Jul 20;35(16):2726-40. doi: 10.1002/sim.6905. Epub 2016 Feb 18.
5
Bootstrap confidence intervals for medical costs with censored observations.带有删失观测值的医疗费用的自助置信区间
Stat Med. 2004 Nov 15;23(21):3365-76. doi: 10.1002/sim.1556.
6
Estimations of competing lifetime data from inverse Weibull distribution under adaptive progressively hybrid censored.自适应逐步混合截尾下逆 Weibull 分布竞争寿命数据的估计。
Math Biosci Eng. 2022 Apr 18;19(6):6252-6275. doi: 10.3934/mbe.2022292.
7
Pointwise confidence intervals for a survival distribution with small samples or heavy censoring.带有小样本或严重删失的生存分布的逐点置信区间。
Biostatistics. 2013 Sep;14(4):723-36. doi: 10.1093/biostatistics/kxt016. Epub 2013 Apr 30.
8
Simple parametric survival analysis with anonymized register data: A cohort study with truncated and interval censored event and censoring times.使用匿名登记数据的简单参数生存分析:一项针对截断和区间删失事件及删失时间的队列研究。
BMC Res Notes. 2011 Aug 25;4:308. doi: 10.1186/1756-0500-4-308.
9
Novel empirical likelihood inference for the mean difference with right-censored data.针对右删失数据均值差异的新型经验似然推断
Stat Methods Med Res. 2022 Jan;31(1):87-104. doi: 10.1177/09622802211041767. Epub 2021 Oct 8.
10
Confidence intervals for the ratio of two median residual lifetimes with left-truncated and right-censored data.具有左截断和右删失数据的两个中位数剩余寿命之比的置信区间。
Biometrics. 2016 Mar;72(1):232-41. doi: 10.1111/biom.12378. Epub 2015 Sep 10.

引用本文的文献

1
Treatment Effect Measures for Culture Conversion Endpoints in Phase IIb Tuberculosis Treatment Trials.二期结核病治疗试验中文化转换终点的治疗效果评估。
Clin Infect Dis. 2021 Dec 6;73(11):2131-2139. doi: 10.1093/cid/ciab576.

本文引用的文献

1
Assessing cytotoxic treatment effects in preclinical tumor xenograft models.评估临床前肿瘤异种移植模型中的细胞毒性治疗效果。
J Biopharm Stat. 2009 Sep;19(5):755-62. doi: 10.1080/10543400903105158.
2
The pediatric preclinical testing program: description of models and early testing results.儿科临床前测试项目:模型描述及早期测试结果
Pediatr Blood Cancer. 2007 Dec;49(7):928-40. doi: 10.1002/pbc.21078.
3
Tumor models for efficacy determination.用于疗效测定的肿瘤模型。
Mol Cancer Ther. 2006 Oct;5(10):2435-43. doi: 10.1158/1535-7163.MCT-06-0391.
4
Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169.LY32262和LY33169的发现及临床前抗肿瘤疗效评估
Invest New Drugs. 2003 Feb;21(1):33-45. doi: 10.1023/a:1022912208877.
5
Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts.拓扑替康与长春新碱联合治疗小儿实体瘤异种移植瘤的协同作用。
Clin Cancer Res. 1999 Nov;5(11):3617-31.
6
Nonparametric estimation for the difference or ratio of median failure times.中位失效时间差异或比率的非参数估计。
Biometrics. 1993 Jun;49(2):603-7.
7
Methods for analysis of censored tumor growth delay data.截尾肿瘤生长延迟数据的分析方法。
Radiat Res. 1990 May;122(2):172-80.